Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.3 | 1.75 |
NAV | ₹10.26 | ₹10.99 |
Fund Started | 25 Jul 2024 | 26 Apr 2024 |
Fund Size | ₹776.63 Cr | ₹11573.71 Cr |
Exit Load | Exit load of 0.50%, if redeemed within 3 months. | Exit load of 1%, if redeemed within 1 month. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -1.72% | -1.03% |
3 Year | - | - |
5 Year | - | - |
1 Year
3 Year
5 Year
Equity | 99.45% | 99.83% |
Cash | 0.55% | 0.17% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Cipla Ltd. | 4.28% |
TVS Motor Company Ltd. | 4.25% |
Mahindra & Mahindra Ltd. | 4.13% |
JK Cement Ltd. | 3.67% |
Varun Beverages Ltd. | 3.58% |
Divi's Laboratories Ltd. | 3.48% |
Bharat Electronics Ltd. | 3.40% |
Lupin Ltd. | 3.37% |
Dixon Technologies (India) Ltd. | 3.09% |
Kaynes Technology India Ltd. | 3.06% |
Name | Assets |
---|---|
Maruti Suzuki India Ltd. | 6.10% |
Reliance Industries Ltd. | 5.12% |
Tata Motors Ltd. | 4.64% |
Divi's Laboratories Ltd. | 3.62% |
Sun Pharmaceutical Industries Ltd. | 3.18% |
Ambuja Cements Ltd. | 2.88% |
JSW Steel Ltd. | 2.85% |
Bosch Ltd. | 2.53% |
Bajaj Auto Ltd. | 2.33% |
Glenmark Pharmaceuticals Ltd. | 2.33% |
Name | Amit Ganatra | Dhruv Muchhal |
Start Date | 01 Sep 2022 | 22 Jun 2023 |
Name
Start Date
Description | The scheme seeks to generate capital appreciation from a diversified portfolio of Equity and Equity Related Instruments of companies following the manufacturing theme. | The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of companies engaged in the manufacturing activity. |
Launch Date | 25 Jul 2024 | 26 Apr 2024 |
Description
Launch Date